Accurate Targeting of Daily Intravenous Busulfan with 8-Hour Blood Sampling in Hospitalized Adult Hematopoietic Cell Transplant Recipients

Daily intravenous (IV) busulfan is increasingly being used in hematopoietic cell transplantation (HCT) conditioning regimens. Intravenous busulfan doses administered at the traditional frequency of every 6 hours can be targeted ((T)Bu) to a patient-specific concentration at steady state (C(ss)) usin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Yeh, Rosa F., Pawlikowski, Matthew A., Blough, David K., McDonald, George B., O’Donnell, Paul V., Rezvani, Andrew, Deeg, H. Joachim, McCune, Jeannine S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3733484/
https://ncbi.nlm.nih.gov/pubmed/21736869
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2011.06.013
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados